ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
182.84
+0.31 (0.17%)
At close: Aug 21, 2026, 4:00 PM EDT
183.00
+0.16 (0.09%)
After-hours: Aug 21, 2026, 7:30 PM EDT

ICU Medical Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, ICU Medical stock has a consensus rating of "Buy" and an average price target of $193.38. The average 1-year stock price forecast is 5.76% higher than the current stock price, while the lowest is $178 (-2.65%) and the highest is $210 (+14.85%).

Price Target: $193.38 (+5.76%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$178$193.38$192.5$210
Change-2.65%+5.76%+5.28%+14.85%

Analyst Ratings

The average analyst rating for ICU Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy333444
Buy334433
Hold110011
Sell000000
Strong Sell000000
Total777888

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Raymond James
Raymond James
Buy
Maintains
$200
BuyMaintains$200+9.39%Aug 7, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$163$195
BuyReiterates$163$195+6.65%Aug 7, 2026
BTIG
BTIG
Buy
Reiterates
$170$200
BuyReiterates$170$200+9.39%Aug 7, 2026
Needham
Needham
Buy
Reiterates
$165$187
BuyReiterates$165$187+2.28%Aug 7, 2026
Jefferies
Jefferies
Buy
Reiterates
$175
BuyReiterates$175-4.29%Jul 14, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
2.19B
from 2.23B
Decreased by -1.82%
Revenue Next Year
2.29B
from 2.19B
Increased by 4.44%
EPS This Year
8.74
from 7.76
Increased by 12.66%
EPS Next Year
9.65
from 8.74
Increased by 10.34%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.32B2.28B2.26B2.38B2.23B2.19B
Revenue Growth
3.56%73.21%-0.92%5.44%-6.33%-1.82%
Gross Profit
491.49M697.76M739.87M824.78M822.04M903.10M
Gross Margin
37.34%30.60%32.75%34.62%36.84%41.23%
Operating Income
141.41M-3.57M47.84M97.41M109.33M361.16M
Net Income
103.14M-74.29M-29.66M-117.69M732.00K90.54M
EPS
----7.768.74
EPS Growth
----24.76%12.66%
Forward PE
47.0933.9233.9233.92178.7220.91
Free Cash Flow
176.31M-144.11M162.25M75.80M393.45M229.00M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High2.2B
Avg2.2B
Low2.2B

Revenue Growth

Revenue Growth202620272028
High
-0.7%
Avg
-1.8%
Low
-2.4%

EPS Forecast

EPS202620272028
High8.83
Avg8.74
Low8.64

EPS Growth

EPS Growth202620272028
High
13.8%
Avg
12.7%
Low
11.3%